These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 1345405
1. [No hypofrontality in schizophrenia demonstrated by positron emission tomography]. Biver F, Delvenne V, Goldman S, Luxen A, De Maertelaer V, Lotstra F, Mendlewicz J. Acta Psychiatr Belg; 1992; 92(5):261-78. PubMed ID: 1345405 [Abstract] [Full Text] [Related]
2. Regional brain function in schizophrenia. I. A positron emission tomography study. Gur RE, Resnick SM, Alavi A, Gur RC, Caroff S, Dann R, Silver FL, Saykin AJ, Chawluk JB, Kushner M. Arch Gen Psychiatry; 1987 Feb; 44(2):119-25. PubMed ID: 3492982 [Abstract] [Full Text] [Related]
3. [Decrease in the frontal-superobasal metabolic ratio in unipolar depression]. François A, Biver F, Goldman S, Luxen A, Mendlewicz J, Lotstra F. Acta Psychiatr Belg; 1995 Feb; 95(4-5):234-45. PubMed ID: 8525862 [Abstract] [Full Text] [Related]
4. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S. Br J Psychiatry; 1990 Feb; 156():216-27. PubMed ID: 2317626 [Abstract] [Full Text] [Related]
9. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography. Gur RE, Resnick SM, Gur RC, Alavi A, Caroff S, Kushner M, Reivich M. Arch Gen Psychiatry; 1987 Feb; 44(2):126-9. PubMed ID: 3492983 [Abstract] [Full Text] [Related]
10. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. Farkas T, Wolf AP, Jaeger J, Brodie JD, Christman DR, Fowler JS. Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333 [Abstract] [Full Text] [Related]
11. Interregional correlation of cerebral glucose metabolism in unmedicated schizophrenia. Biver F, Goldman S, De Maertelaer V, Luxen A, Mendlewicz J, Lotstra F. Eur Neuropsychopharmacol; 1996 May; 6(2):141-7. PubMed ID: 8791040 [Abstract] [Full Text] [Related]
13. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590 [Abstract] [Full Text] [Related]
15. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Wolkin A, Jaeger J, Brodie JD, Wolf AP, Fowler J, Rotrosen J, Gomez-Mont F, Cancro R. Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603 [Abstract] [Full Text] [Related]
16. Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study. Ben-Shachar D, Bonne O, Chisin R, Klein E, Lester H, Aharon-Peretz J, Yona I, Freedman N. Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):807-13. PubMed ID: 17329000 [Abstract] [Full Text] [Related]